User profiles for Richard L.Wahl
Richard L. WahlDirector of Mallinckrodt Institute of Radiology, Washington University School of Medicine … Verified email at wustl.edu Cited by 56331 |
From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors
RL Wahl, H Jacene, Y Kasamon… - Journal of nuclear …, 2009 - Soc Nuclear Med
The purpose of this article is to review the status and limitations of anatomic tumor response
metrics including the World Health Organization (WHO) criteria, the Response Evaluation …
metrics including the World Health Organization (WHO) criteria, the Response Evaluation …
Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants
A rapidly emerging clinical application of positron emission tomography (PET) is the
detection and staging of cancer with the glucose analogue tracer 2-[fluorine-18]fluoro-2-deoxy-d-…
detection and staging of cancer with the glucose analogue tracer 2-[fluorine-18]fluoro-2-deoxy-d-…
Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT
BA Dwamena, SS Sonnad, JO Angobaldo, RL Wahl - Radiology, 1999 - pubs.rsna.org
PURPOSE: To meta-analytically compare 2-[fluorine 18]fluoro-2-deoxy-d-glucose positron
emission tomography (PET) and computed tomography (CT) for the demonstration of …
emission tomography (PET) and computed tomography (CT) for the demonstration of …
[HTML][HTML] 131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
MS Kaminski, M Tuck, J Estes, A Kolstad… - … England Journal of …, 2005 - Mass Medical Soc
Background Advanced-stage follicular B-cell lymphoma is considered incurable. Anti-CD20
radioimmunotherapy is effective in patients who have had a relapse after chemotherapy or …
radioimmunotherapy is effective in patients who have had a relapse after chemotherapy or …
Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction
Background— Recent results from animal studies suggest that stem cells may be able to
home to sites of myocardial injury to assist in tissue regeneration. However, the histological …
home to sites of myocardial injury to assist in tissue regeneration. However, the histological …
Overexpression of glut‐1 glucose transporter in human breast cancer an immunohistochemical study
RS Brown, RL Wahl - Cancer, 1993 - Wiley Online Library
Background. Breast cancers have higher than normal glucose metabolism, but the mechanism
of glucose entry into these tumors is not well understood. Methods. The expression of five …
of glucose entry into these tumors is not well understood. Methods. The expression of five …
Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction.
KR Zasadny, RL Wahl - Radiology, 1993 - pubs.rsna.org
PURPOSE: To study the relationship between standardized uptake values (SUVs) in normal
tissues and body weight determined with positron emission tomography (PET). MATERIALS …
tissues and body weight determined with positron emission tomography (PET). MATERIALS …
[HTML][HTML] Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) Antibody
MS Kaminski, KR Zasadny, IR Francis… - … England Journal of …, 1993 - Mass Medical Soc
Background Many patients with non-Hodgkin's lymphomas are not cured by current therapies,
and new approaches to treatment are needed. As part of an ongoing phase 1 study, we …
and new approaches to treatment are needed. As part of an ongoing phase 1 study, we …
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
RL Wahl, K Zasadny, M Helvie, GD Hutchins… - Journal of Clinical …, 1993 - ascopubs.org
PURPOSE We assessed the feasibility of noninvasive metabolic monitoring of cancer
chemohormonotherapy using sequential quantitative positron emission tomographic (PET) scans …
chemohormonotherapy using sequential quantitative positron emission tomographic (PET) scans …
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
MS Kaminski, AD Zelenetz, OW Press… - Journal of clinical …, 2001 - ascopubs.org
PURPOSE: To evaluate the efficacy and safety of tositumomab and iodine I 131 tositumomab
(Bexxar; Corixa Corp, Seattle, WA, and GlaxoSmithKline, Philadelphia, PA) in patients with …
(Bexxar; Corixa Corp, Seattle, WA, and GlaxoSmithKline, Philadelphia, PA) in patients with …